Page last updated: 2024-11-13
moverastin a
Description
moverastin A: inhibits cancer cell migration; isolated from Aspergillus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (3)
Synonym |
moverastin a |
CHEMBL1683663 |
bdbm50483440 |
Protein Targets (2)
Inhibition Measurements
Biological Processes (9)
Molecular Functions (10)
Ceullar Components (6)
Bioassays (3)
Assay ID | Title | Year | Journal | Article |
AID578269 | Inhibition of protein farnesyltransferase from human EC17 cells using [3H]FPP and GTP-H-Ras | 2011 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 21, Issue:5
| Synthesis and anti-migrative evaluation of moverastin derivatives. |
AID578270 | Cytotoxicity against human EC17 cells assessed as cell viability by trypan blue dye | 2011 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 21, Issue:5
| Synthesis and anti-migrative evaluation of moverastin derivatives. |
AID578271 | Antimigratory activity against human EC17 cells assessed as inhibition of migration after 24 hrs by chemotaxis cell chamber assay | 2011 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 21, Issue:5
| Synthesis and anti-migrative evaluation of moverastin derivatives. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.87 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (40.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 3 (60.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |